Pulmonary manifestations of rheumatic disease

References

• Ellman P, Ball RE. “Rheumatoid disease” with joint and pulmonary manifestations. BMJ 1948: 2(Nov 6): 816–20
   PubMed Web of Science ®Google Scholar
• Gordon DA, Koehler BE, Russell ML, et al. The clinical significance of immune complexes in rheumatoid disease. Ann NY Acad Sei 1975: 256: 338–41
   PubMed Web of Science ®Google Scholar
• Shiel WC Jr, Prete PE. Pleuropulmonary manifestations of rheumatoid arthritis. Semin Arthritis Rheum 1984: 13(3): 235–43
   PubMed Web of Science ®Google Scholar
• Wiedemann HP, Matthay RA. Pulmonary manifestations of the collagen vascular diseases. Clin Chest Med 1989: 10(4): 677–722
   PubMed Web of Science ®Google Scholar
• Caplan A. Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax 1953: 8: 29–37
   PubMed Web of Science ®Google Scholar
• Campbell JA. A case of Caplan s syndrome in a boiler-sealer. Thorax 1958: 13: 177–80
   PubMedGoogle Scholar
• Gordon DA, Hyland RH, Broder I. Rheumatoid arthritis. In: Cannon GW, Zimmerman GA, eds. Lung biology in health and disease. 45. The lung in rheumatic diseases. New York: M Dekker, 1990: 229–59
   Google Scholar
• Turner-Stokes L, Turner-Warwick M. Intrathoracic manifestations of SLE. Clin Rheum Dis 1982: 8(1): 229–42
   PubMedGoogle Scholar
• Matthay RA, Schwarz MI, Petty TL, et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 1975: 54(5): 397–409
   Google Scholar
• Boulware DW, Hedgpeth MT. Lupus pneumonitis and anti-SSA(Ro) antibodies. J Rheumatol 1989: 16(4): 479–81
   PubMed Web of Science ®Google Scholar
• Nair SS, Askari AD, Popelka CG, et al. Pulmonary hypertension and systemic lupus erythematosus. Arch Intern Med 1980: 140(1): 109–11
   PubMedGoogle Scholar
• Schwartzberg M, Lieberman DH, Getzoff B, et al. Systemic lupus erythematosus and pulmonary yascular hypertension. Arch Intern Med 1984: 144(3): 605–7
   PubMedGoogle Scholar
• Hoffbrand BI, Beck ER. “Unexplained” dyspnoea and shrinking lungs in systemic lupus erythematosus. BMJ 1965: 1 (May-15): 1273–7
   PubMedGoogle Scholar
• Wilcox PG, Stein HB, Clarke SD, et al. Phrenic nerve function in patients with diaphragmatic weakness and systemic lupus erythematosus. Chest 1988: 93(2): 352–8
   PubMed Web of Science ®Google Scholar
• de Clerck LS, Dequeker J, Francx L, et al. D-penicillamine therapy and interstitial lung disease in scleroderma: a long-term followup Study Arthritis Rheum 1987: 30(6): 643–50
   PubMedGoogle Scholar
• Epler GR, Colby TV, McLoud TC, et al. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985: 312(3): 152–8
   PubMed Web of Science ®Google Scholar
• Dickey BF, Myers AR. Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum 1984: 14(1): 60–76
   PubMed Web of Science ®Google Scholar
• Schwarz MI, Matthay RA, Sahn SA, et al. Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) 1976: 55(1): 89–104
   Google Scholar
• Salmeron G, Greenberg SD, Lidsky MD. Polymyositis and diffuse interstitial lung disease: a review of the pulmonary histopathologic findings. Arch Intern Med 1981: 141(8): 1005–10
   PubMedGoogle Scholar
• Takizawa H, Shiga J, Moroi Y, et al. Interstitial lung disease in dermatomyositis: clini-copathological study. J Rheumatol 1987: 14(1): 102–7
   PubMed Web of Science ®Google Scholar
• Schumacher HR, Schimmer B, Gordon GV, et al. Articular manifestations of polymyositis and dermatomyositis. Am J Med 1979: 6(2): 287–92
   Web of Science ®Google Scholar
• Songcharoen S, Raju SF, Pennebaker JB. Interstitial lung disease in polymyositis and dermatomyositis. J Rheumatol 1980: 7(3): 353–60
   PubMed Web of Science ®Google Scholar
• Arsura EL, Greenberg AS. Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin Arthritis Rheum 1988: 18(1): 29–37
   PubMed Web of Science ®Google Scholar
• Prakash UB, Luthra HS, Divertie MB. Intrathoracic manifestations in mixed connective tissue disease. Mayo Clin Proc 1985: 60(12): 813–21
   PubMed Web of Science ®Google Scholar
• Sullivan WD, Hurst DJ, Harmon CE, et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 1984: 63(2): 92–107
   Google Scholar
• Wiener-Kronish JP, Solinger AM, Warnock ML, et al. Severe pulmonary involvement in mixed connective tissue disease. Am Rev Respir Dis 1981: 124(4): 499–503
   PubMed Web of Science ®Google Scholar
• Rosenow E, Strimlan CV, Muhm JR, et al. Pleuropulmonary manifestations of ankylosing spondylitis. Mayo Clin Proc 1977: 52(10): 641–9
   PubMed Web of Science ®Google Scholar
• Farquhar DR, Chamberlain MJ, McCain GA, et al. Clearance of inhaled particles in ankylosing spondylitis. Ann Rheum Dis 1989: 48(12): 974–7
   PubMed Web of Science ®Google Scholar
• Boulware DW, Weissman DN, Doll NJ. Pulmonary manifestations of the rheumatic diseases. Clin Rev Allergy 1985: 3(2): 249–67
   PubMedGoogle Scholar
• Karsh J, Pavlidis N, Schiffman G, et al. Immunization of patients with Sjögrens syndrome with pneumococcal polysaccharide vaccine: a randomized trial. Arthritis Rheum 1980: 23(11): 1294–8
   PubMed Web of Science ®Google Scholar
• Lanham JG, Elkon KB, Pusey CD, et al. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984: 63(2): 65–81
   Google Scholar
• Feigin DS. Vasculitis in the lung. J Thorac Imaging 1988: 3(1): 33–48
   PubMedGoogle Scholar
• Fauci AS, Haynes BF, Katz P, et al. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983: 98(1): 76–85
   PubMed Web of Science ®Google Scholar
• Cannon GW. Pulmonary reactions induced by antirheumatic drugs. In: Cannon, Zimmerman, eds, pp 375–98
   Google Scholar